Cardiology Research and Practice

Heart Disease and Cancer: Mechanisms and Clinical Management


Publishing date
01 Nov 2021
Status
Closed
Submission deadline
18 Jun 2021

Lead Editor
Guest Editors

1Chinese PLA General Hospital, Beijing, China

2University of Minnesota, Duluth, USA

3University of Wyoming, Laramie, USA

This issue is now closed for submissions.
More articles will be published in the near future.

Heart Disease and Cancer: Mechanisms and Clinical Management

This issue is now closed for submissions.
More articles will be published in the near future.

Description

Cancer and cardiovascular disease (CVD) are the two most common causes of mortality and morbidity worldwide. It has been estimated that 17.7 million people die annually as a consequence of cardiovascular diseases, whereas cancer accounts for 8.8 million deaths per year. Evidence linking cardiovascular diseases with a higher incidence of cancer has been suggested previously in many clinical trials and animal experiments. Emerging literature suggests that modifiable risk factors including diet, sedentary lifestyle, obesity, and tobacco use are central to the pathogenesis of both diseases and are reflected in common genetic, cellular, and signaling mechanisms. Understanding this important biological overlap is critical and may help identify novel therapeutic and preventative strategies for both disorders.

Extensive knowledge has already been gained concerning cancer treatment-related cardiotoxicity, although the molecular mechanism and medical practice are largely unknown and need further in-depth investigation. In addition, the common pathological factors underlying CVD and CVD-related cancers have not been fully explored. Several prediction models taking into account the full spectrum of late effects are needed to guide primary treatment choice and appropriate follow-up after cancer treatment. Although a growing body of evidence supports a role for aspirin, statins, ACE inhibitors/ARBs, metformin, and TZDs in cancer prevention and CVD treatment, it remains of outstanding interest to design, develop, and validate the pharmacologic and non-pharmacologic preventive approaches for the treatment of CVD and CVD-related cancers.

The goal of this Special Issue is to understand the recent advances in the clinical treatment and management of CVD and CVD-related cancers. We invite authors to submit original research and review articles that will stimulate the continuing efforts in elucidating the epidemiology, diagnostic strategies, therapeutic approaches, preventive models, and prognostic analysis of CVD and CVD-related cancers.

Potential topics include but are not limited to the following:

  • Molecular mechanisms and diagnostic strategies of CVD-related cancers, such as breast cancer, lung cancer, and hematologic tumors
  • Clinical features of patients with severe CVD or CVD-related cancers
  • Circulating biomarkers in the diagnosis and prognostic analysis of CVD or cancers-related CVD
  • Recent advances in medical imaging in patients with CVD or CVD-related cancers
  • Pharmacologic and non-pharmacologic preventive approaches for the treatment of CVD and CVD-related cancers
  • Statistical models in the early diagnosis, rapid detection, and efficacy evaluation of patients with CVD or CVD-related cancers

Articles

  • Special Issue
  • - Volume 2021
  • - Article ID 3300884
  • - Research Article

Value of Follow-Up N-Terminal Probrain Natriuretic Peptide (NT-proBNP) after a Modified Fontan Procedure

Jianbin Li | Li Ma | ... | Xiaoyan Hu
  • Special Issue
  • - Volume 2021
  • - Article ID 3925136
  • - Research Article

Decreased Spp1 Expression in Acute Myocardial Infarction after Ischemia and Reperfusion Injury

Ling Li | Jungang Huang | ... | Shi Liang
  • Special Issue
  • - Volume 2021
  • - Article ID 3483976
  • - Research Article

Verifying the Usefulness of Pulmonary Blood Flow Studies in the Correction of Pulmonary Atresia and Ventricular Septal Defect with Major Aortopulmonary Collateral Arteries

Zirou Huang | Fan Cao | ... | Xinxin Chen
  • Special Issue
  • - Volume 2021
  • - Article ID 1948624
  • - Research Article

Patients with New-Onset Tumor of Severe Coronary Artery Disease May be at a Higher Risk of Arrhythmia

Palisha Alimu | Dezhi Yang | ... | Huiping Guo
  • Special Issue
  • - Volume 2021
  • - Article ID 2970568
  • - Research Article

High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients

Ziyang Hu | Jingle Cui | ... | Shibin Zhang
  • Special Issue
  • - Volume 2021
  • - Article ID 5667364
  • - Research Article

Clinical Study on Long-Term Sinus Reversion Rate and Left Atrial Function Recovery of Mitral Valve Disease with Atrial Fibrillation under Modified Surgical Radiofrequency Ablation

Jingle Cui | Ziyang Hu | ... | Zhiyong Huang
  • Special Issue
  • - Volume 2021
  • - Article ID 2283018
  • - Research Article

Development and Validation of a Risk Prediction Model for Ventricular Arrhythmia in Elderly Patients with Coronary Heart Disease

Ying Dong | Yajun Shi | ... | Xueping Wang
  • Special Issue
  • - Volume 2021
  • - Article ID 1625915
  • - Research Article

The Long-Term Change of Arrhythmias after Transcatheter Closure of Perimembranous Ventricular Septal Defects

Hongyan Zheng | Aiwen Lin | ... | Zhiwei Zhang
  • Special Issue
  • - Volume 2021
  • - Article ID 9947034
  • - Research Article

Establishment of a Nomogram for Predicting Early Death in Viral Myocarditis

Xuejun Sun | Naxin Xie | ... | Hongmu Li
Cardiology Research and Practice
 Journal metrics
Acceptance rate28%
Submission to final decision77 days
Acceptance to publication36 days
CiteScore1.600
Journal Citation Indicator0.370
Impact Factor1.866
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.